ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $100,000 | -95.9% | 83,302 | -94.8% | 0.00% | -100.0% |
Q3 2019 | $2,411,000 | -60.0% | 1,596,601 | +6.4% | 0.00% | 0.0% |
Q2 2019 | $6,031,000 | -6.5% | 1,500,127 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $6,451,000 | -25.2% | 1,500,127 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $8,626,000 | -57.6% | 1,500,127 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $20,342,000 | +11.0% | 1,500,127 | -2.8% | 0.00% | 0.0% |
Q2 2018 | $18,320,000 | +8.2% | 1,543,366 | +2.3% | 0.00% | 0.0% |
Q1 2018 | $16,934,000 | +321.1% | 1,507,965 | +150.5% | 0.00% | +300.0% |
Q4 2017 | $4,021,000 | -20.4% | 601,878 | -2.5% | 0.00% | 0.0% |
Q3 2017 | $5,053,000 | +98.6% | 617,003 | +8.9% | 0.00% | 0.0% |
Q2 2017 | $2,544,000 | -24.2% | 566,553 | -6.9% | 0.00% | 0.0% |
Q1 2017 | $3,354,000 | +59.7% | 608,633 | +17.4% | 0.00% | 0.0% |
Q4 2016 | $2,100,000 | -48.1% | 518,523 | -9.6% | 0.00% | 0.0% |
Q3 2016 | $4,045,000 | -5.7% | 573,723 | +9.0% | 0.00% | 0.0% |
Q2 2016 | $4,288,000 | -1.2% | 526,123 | -1.4% | 0.00% | 0.0% |
Q1 2016 | $4,339,000 | -38.0% | 533,643 | -8.0% | 0.00% | -50.0% |
Q4 2015 | $6,997,000 | – | 580,173 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |